Scorpion Therapeutics

Scorpion Therapeutics is a pioneering biotechnology research company dedicated to developing the next generation of precision oncology treatments. With a focus on creating transformational targeted therapies for cancer patients, Scorpion Therapeutics utilizes cutting-edge technologies across cancer biology, medicinal chemistry, and data sciences. The company is committed to addressing unmet needs in cancer therapy by discovering and developing highly selective product candidates against well-validated targets, ultimately improving patient outcomes.

Scorpion Therapeutics' fully integrated discovery capabilities have led to a robust pipeline, including the mutant-selective PI3Ka program STX-478. With multiple internally discovered clinical product candidates and a range of discovery-stage programs, Scorpion Therapeutics is at the forefront of innovation in the biotechnology sector. The company's dedication to precision oncology positions it as a key player in the future of cancer treatment.

Scorpion Therapeutics is dedicated to advancing cancer care through groundbreaking research and development. The company's commitment to innovation and patient outcomes drives its mission to deliver transformational therapies. We invite the manager of Scorpion Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions to the biotechnology field.